Nexus AG, specialized in hospital software, was able to improve sales by 8.7% and its result before interest and taxes (EBIT) by 14.6% in the first nine months of 2020. As a result, the successful positive development of sales and earnings of NEXUS Group of recent years has been continued.
In the first nine months 2020, sales increased from KEUR 106,196 (9M 2019) to KEUR 115,474. Consolidated earnings before interest and revenue tax (EBIT) increased by 14.6% from KEUR 11,184 (9M 2019) to KEUR 12,818. EBITA increased by 9.6% from KEUR 14,307 (9M 2019) to KEUR 15,685. EBITDA reached KEUR 24,762 in the first nine months 2020 and consequently increased by 6.1% (9M 2019: KEUR 23,332). The consolidated surplus amounted to KEUR 9,024 (9M 2019: KEUR 7,768) and consequently increa¬sed by 16.2%.
The operating cash flow reached a value of KEUR 26,882 (9M 2019: KEUR 24,683). Nexus AG had cash funds incl. short-term financial assets amounting to KEUR 30,601 as of 30 Septem¬ber 2020 (30 September 2019: KEUR 32,499). Dividends in the amount of KEUR 2,835 (2019: KEUR 2,676) were paid to our stockholders in 2020. The result per share was EUR 0.56 in the first nine months of 2020 (2019: EUR 0.42).
Nexus AG has equity capital amounting to KEUR 119,134 (31 December 2019: KEUR 115,135). This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.
The detailed Quarterly Report can be found on our homepage at:
https://en-en.nexus-ag.de/company/investor-relations - Financial Reports
|Contact Person:||Hannes Wehinger|
|Phone:||+49 771 - 22960 258|
|Stock Exchange(s):||Regulated Market in Frankfurt, Hamburg; Free Market in Berlin, Dusseldorf, Munich, Stuttgart|